
"Nasal Vaccine Shows Promise in Preventing COVID-19, Say Researchers"
Researchers at the University of Maryland have developed a nasal spray vaccine that effectively prevents COVID-19 in preclinical studies with mice and hamsters. The vaccine delivers the SARS-CoV-2 spike protein into the airway cells, triggering an immune response that significantly reduces infection and transmission of the virus. This technology can also be adapted to provide immunity against other respiratory illnesses. The nasal vaccine offers a less invasive and more efficient method of vaccination, targeting the cells in the nose, mouth, and throat, where the virus enters the body. The development of this nasal vaccine could help improve vaccination rates and reduce the spread of COVID-19.




